Literature DB >> 12653421

Context-processing deficits in schizophrenia: diagnostic specificity, 4-week course, and relationships to clinical symptoms.

Deanna M Barch1, Cameron S Carter, Angus W MacDonald, Todd S Braver, Jonathan D Cohen.   

Abstract

Previous research on schizophrenia suggests that context-processing disturbances are one of the core cognitive deficits present in schizophia. However, it is not clear whether such deficits are specific to schizophrenia as compared with other psychotic disorders. To address this question, the authors administered a version of the AX Continuous Performance Test designed to assess context processing in a sample of healthy controls, patients with schizophrenia, and patients with other psychotic disorders. Participants were tested at index (when medication naive and experiencing their first contact with psychiatric services) and 4 weeks later, following medication treatment. At index, patients with schizophrenia and the psychotic comparison group demonstrated similar impairments in context processing. However, context-processing deficits improved in the psychotic comparison group at 4 weeks but did not improve in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653421

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  104 in total

1.  General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

Authors:  Alex Fornito; Jong Yoon; Andrew Zalesky; Edward T Bullmore; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

Review 2.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 3.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

4.  Automated classification of fMRI during cognitive control identifies more severely disorganized subjects with schizophrenia.

Authors:  Jong H Yoon; Danh V Nguyen; Lindsey M McVay; Paul Deramo; Michael J Minzenberg; J Daniel Ragland; Tara Niendham; Marjorie Solomon; Cameron S Carter
Journal:  Schizophr Res       Date:  2012-01-25       Impact factor: 4.939

5.  Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia.

Authors:  R Y Cho; R O Konecky; C S Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-14       Impact factor: 11.205

6.  Impaired prefrontal functional connectivity associated with working memory task performance and disorganization despite intact activations in schizophrenia.

Authors:  Sripriya Chari; Michael J Minzenberg; Marjorie Solomon; J Daniel Ragland; Quynh Nguyen; Cameron S Carter; Jong H Yoon
Journal:  Psychiatry Res Neuroimaging       Date:  2019-03-19       Impact factor: 2.376

7.  Altered cognitive development in the siblings of individuals with schizophrenia.

Authors:  Deanna M Barch; Rachel Cohen; John Csernansky
Journal:  Clin Psychol Sci       Date:  2014-03-01

8.  Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches.

Authors:  Keith H Nuechterlein; Joseph Ventura; Kenneth L Subotnik; Jacqueline N Hayata; Alice Medalia; Morris D Bell
Journal:  Am J Psychiatr Rehabil       Date:  2014-07

Review 9.  Neurocognitive mechanisms of conceptual processing in healthy adults and patients with schizophrenia.

Authors:  Tatiana Sitnikova; Christopher Perrone; Donald Goff; Gina R Kuperberg
Journal:  Int J Psychophysiol       Date:  2009-12-07       Impact factor: 2.997

10.  Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.

Authors:  Daniel Fulford; Tara A Niendam; Erin G Floyd; Cameron S Carter; Daniel H Mathalon; Sophia Vinogradov; Barbara K Stuart; Rachel L Loewy
Journal:  Schizophr Res       Date:  2013-04-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.